Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Cytomegalovirus (CMV) Diagnostic Market by Type (Blood, Urine), By Application (Hospitals, Diagnostic Centers and Clinics, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Cytomegalovirus (CMV) Diagnostic Market by Type (Blood, Urine), By Application (Hospitals, Diagnostic Centers and Clinics, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 237412 4200 Medical Devices & Consumables 377 173 Pages 4.9 (37)
                                          

Market Overview:


The global cytomegalovirus (CMV) diagnostic market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The CMV diagnostic market is segmented on the basis of type, application, and region. On the basis of type, the CMV diagnostic market is segmented into blood and urine tests. The blood test segment dominates the CMV diagnostic market owing to its high accuracy in diagnosing CMV infections. On the basis of application, hospitals account for a major share of the global CMV diagnostic market followed by clinics and other end users such as research laboratories and pharmaceutical companies.


Global Cytomegalovirus (CMV) Diagnostic Industry Outlook


Product Definition:


A cytomegalovirus (CMV) diagnostic is a blood or tissue test used to detect the presence of the cytomegalovirus (CMV) virus. The test can help doctors diagnose CMV infections and determine if someone is at risk for developing complications from a CMV infection.


Blood:


The global blood market size was valued at USD 1.8 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The increasing prevalence of infectious diseases, such as HIV-AIDS, CMV infection and others are fueling the growth factor for this industry globally.


Urine:


Urine is a body fluid that is produced in the kidneys and passed from the body through the urethra. It plays an important role in maintaining hydration levels of the human body as well as helps remove toxins from it. Urine also acts as a medium to transport waste products out of cells and tissues for removal by the urinary system.


Application Insights:


The hospitals segment dominated the market in 2017 and is expected to maintain its lead over the forecast period. This can be attributed to factors such as government initiatives for improving healthcare infrastructure, increasing spending on medical devices and diagnostics, rising awareness about preventive healthcare measures, growing geriatric population base (i.e., people aged 60 years & above), and favorable reimbursement policies that encourage adoption of diagnostic technologies.


CMV is a major concern in hospitals due to high prevalence of immunocompromised patients (i.e., patients suffering from diseases such as AIDS) who are more susceptible to infection by CMV or any other virus owing to their reduced immunity.


Regional Analysis:


North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure and high adoption rate for novel diagnostic products are some factors responsible for its large share. In addition, favorable reimbursement policies in this region are also expected to drive the demand over the forecast period.


Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing awareness about CMV infection and rising incidence of cancer due to exposure to tobacco smoke or asbestos among others reasons driving a need for early diagnosis leading it towards lucrative growth over the projected time frame.


Infection with cytomegalovirus (CMV) causes disease by inducing permanent damage which may lead toward development of malignancy or organ failure among others resulting into increased mortality rate amongst infected individuals [1].


Growth Factors:


  • Increasing incidence of CMV infections: The incidence of CMV infections is increasing due to the growing population and their changing lifestyle. This is driving the demand for better diagnostic tests for early diagnosis and treatment of CMV infection.
  • Growing awareness about CMV infections: There is growing awareness among people about the symptoms, transmission, and prevention of CMV infections. This is driving the demand for better diagnostic tests for early diagnosis and treatment of CMV infection.
  • Technological advancements in diagnostics: There has been a significant advancement in diagnostics technology in recent years that has led to development of new and more accurate diagnostic tests for detection ofCMV infection. This is driving the demand for these new diagnostic tests, which are helping to improve accuracy and speed up diagnosis process..

Scope Of The Report

Report Attributes

Report Details

Report Title

Cytomegalovirus (CMV) Diagnostic Market Research Report

By Type

Blood, Urine

By Application

Hospitals, Diagnostic Centers and Clinics, Others

By Companies

Abbott Laboratories, bioMérieux, BD Biosciences, Bio-Rad Laboratories, Roche, Bioneer Corp, Siemens Healthcare, Thermo Fisher Scientific, Realstar Group, Merck, Qiagen, Guangdong Hybribio, Sansure Biotech

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

173

Number of Tables & Figures

122

Customization Available

Yes, the report can be customized as per your need.


Global Cytomegalovirus (CMV) Diagnostic Market Report Segments:

The global Cytomegalovirus (CMV) Diagnostic market is segmented on the basis of:

Types

Blood, Urine

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospitals, Diagnostic Centers and Clinics, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Abbott Laboratories
  2. bioMérieux
  3. BD Biosciences
  4. Bio-Rad Laboratories
  5. Roche
  6. Bioneer Corp
  7. Siemens Healthcare
  8. Thermo Fisher Scientific
  9. Realstar Group
  10. Merck
  11. Qiagen
  12. Guangdong Hybribio
  13. Sansure Biotech

Global Cytomegalovirus (CMV) Diagnostic Market Overview


Highlights of The Cytomegalovirus (CMV) Diagnostic Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Blood
    2. Urine
  1. By Application:

    1. Hospitals
    2. Diagnostic Centers and Clinics
    3. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Cytomegalovirus (CMV) Diagnostic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Cytomegalovirus (CMV) Diagnostic Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


CMV is a virus that can cause serious health problems in people of all ages. It is most commonly spread through contact with respiratory secretions, such as saliva or mucus, from an infected person. CMV can also be spread through close contact with objects or surfaces that have been contaminated with the virus. Symptoms of CMV infection vary depending on the age and health of the person infected, but may include fever, body aches and tiredness, sore throat, swollen lymph nodes (glands), diarrhea and vomiting. In severe cases, CMV infection can lead to pneumonia (a lung infection) or even death. If you think you may have contracted CMV-related illness, please see your doctor for a diagnosis.

Some of the major companies in the cytomegalovirus (cmv) diagnostic market are Abbott Laboratories, bioM©rieux, BD Biosciences, Bio-Rad Laboratories, Roche, Bioneer Corp, Siemens Healthcare, Thermo Fisher Scientific, Realstar Group, Merck, Qiagen, Guangdong Hybribio, Sansure Biotech.

The cytomegalovirus (cmv) diagnostic market is expected to grow at a compound annual growth rate of 7.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cytomegalovirus (CMV) Diagnostic Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Cytomegalovirus (CMV) Diagnostic Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Cytomegalovirus (CMV) Diagnostic Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Cytomegalovirus (CMV) Diagnostic Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Cytomegalovirus (CMV) Diagnostic Market Size & Forecast, 2018-2028       4.5.1 Cytomegalovirus (CMV) Diagnostic Market Size and Y-o-Y Growth       4.5.2 Cytomegalovirus (CMV) Diagnostic Market Absolute $ Opportunity

Chapter 5 Global Cytomegalovirus (CMV) Diagnostic Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Type
      5.2.1 Blood
      5.2.2 Urine
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Cytomegalovirus (CMV) Diagnostic Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Applications
      6.2.1 Hospitals
      6.2.2 Diagnostic Centers and Clinics
      6.2.3 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Cytomegalovirus (CMV) Diagnostic Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Cytomegalovirus (CMV) Diagnostic Analysis and Forecast
   9.1 Introduction
   9.2 North America Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Type
      9.6.1 Blood
      9.6.2 Urine
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Applications
      9.10.1 Hospitals
      9.10.2 Diagnostic Centers and Clinics
      9.10.3 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Cytomegalovirus (CMV) Diagnostic Analysis and Forecast
   10.1 Introduction
   10.2 Europe Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Type
      10.6.1 Blood
      10.6.2 Urine
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Applications
      10.10.1 Hospitals
      10.10.2 Diagnostic Centers and Clinics
      10.10.3 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Cytomegalovirus (CMV) Diagnostic Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Type
      11.6.1 Blood
      11.6.2 Urine
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Applications
      11.10.1 Hospitals
      11.10.2 Diagnostic Centers and Clinics
      11.10.3 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Cytomegalovirus (CMV) Diagnostic Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Type
      12.6.1 Blood
      12.6.2 Urine
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Applications
      12.10.1 Hospitals
      12.10.2 Diagnostic Centers and Clinics
      12.10.3 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Cytomegalovirus (CMV) Diagnostic Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Type
      13.6.1 Blood
      13.6.2 Urine
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Applications
      13.10.1 Hospitals
      13.10.2 Diagnostic Centers and Clinics
      13.10.3 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Cytomegalovirus (CMV) Diagnostic Market: Competitive Dashboard
   14.2 Global Cytomegalovirus (CMV) Diagnostic Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Abbott Laboratories
      14.3.2 bioMérieux
      14.3.3 BD Biosciences
      14.3.4 Bio-Rad Laboratories
      14.3.5 Roche
      14.3.6 Bioneer Corp
      14.3.7 Siemens Healthcare
      14.3.8 Thermo Fisher Scientific
      14.3.9 Realstar Group
      14.3.10 Merck
      14.3.11 Qiagen
      14.3.12 Guangdong Hybribio
      14.3.13 Sansure Biotech

Our Trusted Clients

Contact Us